{"id":389086,"date":"2020-11-27T10:42:16","date_gmt":"2020-11-27T15:42:16","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=389086"},"modified":"2020-11-27T10:42:16","modified_gmt":"2020-11-27T15:42:16","slug":"applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/","title":{"rendered":"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3"},"content":{"rendered":"

<\/p>\n

Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3<\/b><\/p>\n

STONY BROOK, N.Y.–(BUSINESS WIRE<\/a>)–
\nApplied DNA Sciences, Inc. (NASDAQ: APDN) (\u201cApplied DNA\u201d or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that it is scheduled to participate virtually in the Imperial Capital 2020 Security Investor Conference on Thursday, December 3, 2020. Dr. James A. Hayward, chief executive officer, will present at 10:45 a.m. EST that day and host one-on-one meetings throughout the day.\n<\/p>\n

\nAn archived webcast will be available within 24 hours of the live presentation on the \u201cIR Calendar\u201d section of the Applied DNA Investor Relations page at adnas.com<\/a>.\n<\/p>\n

About Applied DNA Sciences <\/b><\/p>\n

\nApplied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates.\n<\/p>\n

\nVisit adnas.com for more information. Follow us on Twitter <\/a>and LinkedIn<\/a>. Join our mailing list<\/a>.\n<\/p>\n

\nThe Company\u2019s common stock is listed on NASDAQ under ticker symbol \u2018APDN\u2019, and its publicly traded warrants are listed on OTC under ticker symbol \u2018APPDW\u2019.\n<\/p>\n

\nApplied DNA is a member of the Russell Microcap\u00ae Index.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201127005489\/en\/<\/a><\/span><\/p>\n

Investor contact: <\/b>Sanjay M. Hurry, Applied DNA Sciences, 917-733-5573, sanjay.hurry@adnas.com<\/a>
Web:<\/b>www.adnas.com
\n<\/a>
Twitter: <\/b>@APDN\n<\/p>\n

KEYWORDS:<\/b> New York United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Professional Services Security Health Technology Finance Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 STONY BROOK, N.Y.–(BUSINESS WIRE)– Applied DNA Sciences, Inc. (NASDAQ: APDN) (\u201cApplied DNA\u201d or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that it is scheduled to participate virtually in the Imperial Capital 2020 Security Investor Conference on Thursday, December 3, 2020. Dr. James A. Hayward, chief executive officer, will present at 10:45 a.m. EST that day and host one-on-one meetings throughout the day. An archived webcast will be available within 24 hours of the live presentation on the \u201cIR Calendar\u201d section of the Applied DNA Investor Relations page at adnas.com. About Applied DNA Sciences Applied DNA is a provider of molecular … <\/p>\n

Continue reading “Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-389086","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nApplied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 STONY BROOK, N.Y.–(BUSINESS WIRE)– Applied DNA Sciences, Inc. (NASDAQ: APDN) (\u201cApplied DNA\u201d or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that it is scheduled to participate virtually in the Imperial Capital 2020 Security Investor Conference on Thursday, December 3, 2020. Dr. James A. Hayward, chief executive officer, will present at 10:45 a.m. EST that day and host one-on-one meetings throughout the day. An archived webcast will be available within 24 hours of the live presentation on the \u201cIR Calendar\u201d section of the Applied DNA Investor Relations page at adnas.com. About Applied DNA Sciences Applied DNA is a provider of molecular … Continue reading "Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-27T15:42:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201127005489r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3\",\"datePublished\":\"2020-11-27T15:42:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/\"},\"wordCount\":255,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201127005489r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/\",\"name\":\"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201127005489r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-11-27T15:42:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201127005489r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201127005489r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/","og_locale":"en_US","og_type":"article","og_title":"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 - Market Newsdesk","og_description":"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 STONY BROOK, N.Y.–(BUSINESS WIRE)– Applied DNA Sciences, Inc. (NASDAQ: APDN) (\u201cApplied DNA\u201d or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that it is scheduled to participate virtually in the Imperial Capital 2020 Security Investor Conference on Thursday, December 3, 2020. Dr. James A. Hayward, chief executive officer, will present at 10:45 a.m. EST that day and host one-on-one meetings throughout the day. An archived webcast will be available within 24 hours of the live presentation on the \u201cIR Calendar\u201d section of the Applied DNA Investor Relations page at adnas.com. About Applied DNA Sciences Applied DNA is a provider of molecular … Continue reading \"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-27T15:42:16+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201127005489r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3","datePublished":"2020-11-27T15:42:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/"},"wordCount":255,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201127005489r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/","name":"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201127005489r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-11-27T15:42:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201127005489r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201127005489r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/applied-dna-to-present-at-the-imperial-capital-2020-security-investor-conference-on-december-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=389086"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389086\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=389086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=389086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=389086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}